Novel therapy in Parkinson's disease: adenosine A(2A) receptor antagonists.
about
Adenosine A(2A) Receptor Antagonists and Parkinson's DiseaseNicotine as a potential neuroprotective agent for Parkinson's disease.Clinical utility of neuroprotective agents in neurodegenerative diseases: current status of drug development for Alzheimer's, Parkinson's and Huntington's diseases, and amyotrophic lateral sclerosis.Suitability of the adenosine antagonist istradefylline for the treatment of Parkinson's disease: pharmacokinetic and clinical considerations.Clinical implications of irregular ADMET properties with levodopa and other antiparkinson's drugs.The safety of istradefylline for the treatment of Parkinson's disease.Promising therapeutic agents for the treatment of Parkinson's disease.Attenuation of Clostridium difficile toxin-induced damage to epithelial barrier by ecto-5'-nucleotidase (CD73) and adenosine receptor signaling.Purine metabolism gene deregulation in Parkinson's disease.Pharmacophore generation, atom-based 3D-QSAR, HQSAR and activity cliff analyses of benzothiazine and deazaxanthine derivatives as dual A2A antagonists/MAO‑B inhibitors.
P2860
Q29346492-90F6E272-21E6-4FE1-86CC-3F2058615FB2Q34281003-E4639D55-B61B-476B-BFB6-C8D173549729Q38022265-0EE1F295-14A2-4AF0-BAF3-B607523D18AEQ38103966-CF3B45D6-2FF6-4C68-A592-772882ADF325Q38179453-52C67D09-F32C-4EDE-90C7-FCB215722A2EQ38353204-A3457E53-A7E1-4660-AB1E-E4A198CBF542Q38767711-0C66404E-5406-487F-AFD1-207B4B839F28Q39163750-2F6D9A28-F516-455C-A933-16C791143136Q48371760-C8E19D50-3013-4D5E-985F-B512E079A7A3Q50880865-F65C09D5-A205-4D51-B443-2107FE6F3966
P2860
Novel therapy in Parkinson's disease: adenosine A(2A) receptor antagonists.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 19 February 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Novel therapy in Parkinson's disease: adenosine A
@nl
Novel therapy in Parkinson's disease: adenosine A(2A) receptor antagonists.
@en
type
label
Novel therapy in Parkinson's disease: adenosine A
@nl
Novel therapy in Parkinson's disease: adenosine A(2A) receptor antagonists.
@en
prefLabel
Novel therapy in Parkinson's disease: adenosine A
@nl
Novel therapy in Parkinson's disease: adenosine A(2A) receptor antagonists.
@en
P2860
P1476
Novel therapy in Parkinson's disease: adenosine A(2A) receptor antagonists
@en
P2093
Nikoletta Szabó
P2860
P304
P356
10.1517/17425255.2011.557066
P407
P577
2011-02-19T00:00:00Z